CENES

Welcome to the Brand page for “CENES”, which is offered here for Computer hardware, experimental apparatus and instrumentation, and computer software and hardware for cognitive, psychological, and neuropsychological testing; cognition and neuropsychological testing systems employing visual tests displayed on a computer screen for testing humans and animals composed of computer software and computer hardware; scientific and laboratory apparatus and instruments for electrophysiological testing; computer software for controlling cognitive psychological and neuropsychological testing apparatus scientific and laboratory apparatus and instruments for electrophysiological testing, and operant chambers for animal testing; database management software and electronic databases in the field of cognitive, psychological, and neuropsychological testing recorded on computer media; touch screen apparatus for all the aforesaid; and parts and fittings for all the aforesaid;drugs for the management of pain and related conditions; pain control drugs; drugs for the treatment of neurodegenerative diseases and neurological and psychiatric disorders; drugs for the treatment of cognitive and motor disorders; drugs for use in connection with drug abuse; analgesics; and ion channel modulators;biotechnology research and development; neurological, pharmaceutical, and genetic research and development; drug discovery, design, and research and development; research and development relating to ion channel modulators, neurodegeneractive diseases, analgesics, and pain control; neuropsychological and diagnostic testing, research and development; consultancy services relating to all the aforesaid;.

Its status is currently believed to be active. Its class is unavailable. “CENES” is believed to be currently owned by “CeNeS Limited”.


Owner:
CENES LIMITED
Owner Details
Description:
COMPUTER HARDWARE, EXPERIMENTAL APPARATUS AND INSTRUMENTATION, AND COMPUTER SOFTWARE AND HARDWARE FOR COGNITIVE, PSYCHOLOGICAL, AND NEUROPSYCHOLOGICAL TESTING; COGNITION AND NEUROPSYCHOLOGICAL TESTING SYSTEMS EMPLOYING VISUAL TESTS DISPLAYED ON A COMPUTER SCREEN FOR TESTING HUMANS AND ANIMALS COMPOSED OF COMPUTER SOFTWARE AND COMPUTER HARDWARE; SCIENTIFIC AND LABORATORY APPARATUS AND INSTRUMENTS FOR ELECTROPHYSIOLOGICAL TESTING; COMPUTER SOFTWARE FOR CONTROLLING COGNITIVE PSYCHOLOGICAL AND NEUROPSYCHOLOGICAL TESTING APPARATUS SCIENTIFIC AND LABORATORY APPARATUS AND INSTRUMENTS FOR ELECTROPHYSIOLOGICAL TESTING, AND OPERANT CHAMBERS FOR ANIMAL TESTING; DATABASE MANAGEMENT SOFTWARE AND ELECTRONIC DATABASES IN THE FIELD OF COGNITIVE, PSYCHOLOGICAL, AND NEUROPSYCHOLOGICAL TESTING RECORDED ON COMPUTER MEDIA; TOUCH SCREEN APPARATUS FOR ALL THE AFORESAID; AND PARTS AND FITTINGS FOR ALL THE AFORESAID;DRUGS FOR THE MANAGEMENT OF PAIN AND RELATED CONDITIONS; PAIN CONTROL DRUGS; DRUGS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AND NEUROLOGICAL AND PSYCHIATRIC DISORDERS; DRUGS FOR THE TREATMENT OF COGNITIVE AND MOTOR DISORDERS; DRUGS FOR USE IN CONNECTION WITH DRUG ABUSE; ANALGESICS; AND ION CHANNEL MODULATORS;BIOTECHNOLOGY RESEARCH AND DEVELOPMENT; NEUROLOGICAL, PHARMACEUTICAL, AND GENETIC RESEARCH AND DEVELOPMENT; DRUG DISCOVERY, DESIGN, AND RESEARCH AND DEVELOPMENT; RESEARCH AND DEVELOPMENT RELATING TO ION CHANNEL MODULATORS, NEURODEGENERACTIVE DISEASES, ANALGESICS, AND PAIN CONTROL; NEUROPSYCHOLOGICAL AND DIAGNOSTIC TESTING, RESEARCH AND DEVELOPMENT; CONSULTANCY SERVICES RELATING TO ALL THE AFORESAID;
Categories: COMPUTER HARDWARE